Ibrance
Brand Name: Ibrance
Generic Name: Palbociclib
Active
Registration Number
DR-XY48906
Dosage Form
Film-Coated Tablet
Issuance Date
October 20, 2023
Expiry Date
October 20, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength75 mg
PackagingAlu-PVC/OPA/Alu/PVC blister pack x 7's (Box of 7's)
Classification
C
Classification
Prescription (Rx) Drug
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
PalbociclibActive
Monograph: Palbociclib